AtriCure Stock

AtriCure EPS

The Earnings per Share (EPS) of AtriCure (ATRC) as of Aug 3, 2026 is -0.23 USD. In the previous year, Earnings per Share (EPS) was -0.95 USD — a change of -75.31% (higher).

EPS

-0.23USD

YoY

-75.31%

Last updated:

Earnings per Share (EPS) of AtriCure is 2026 -0.23 USD. Earnings per Share (EPS) of AtriCure was 2025 -0.95 USD. It decreases by -75.31% higher compared to the previous year.
Access this data via the Eulerpool API

AtriCure Stock analysis

What does AtriCure do? AtriCure Inc is a medical technology company that specializes in the development of innovative products and therapies for the treatment of cardiac arrhythmias. It was founded in 2000 and is headquartered in Mason, Ohio, USA. The company offers a wide range of products and therapies, including the isolation of pulmonary veins, catheter technology, radiofrequency ablation, and innovative solutions for the treatment of heart valve diseases and other structural heart problems. AtriCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtriCure stock

Earnings per Share (EPS) of AtriCure is -0.23 USD in 2026.

Earnings per Share (EPS) of AtriCure changed from -0.95 USD to -0.23 USD, representing a -75.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) AtriCure since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — AtriCure

All Key Metrics — AtriCure